help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muir, D.
Right arrow Articles by Wallace, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muir, D.
Right arrow Articles by Wallace, M. R.
(American Journal of Pathology. 2001;158:501-513.)
© 2001 American Society for Investigative Pathology

Regular Article

Tumorigenic Properties of Neurofibromin-Deficient Neurofibroma Schwann Cells

David Muir*, Debbie Neubauer*, Ingrid T. Lim*, Anthony T. Yachnis{dagger} and Margaret R. Wallace{ddagger}

From the Divisions of Neurology*
and Genetics,{ddagger}
the Department of Pediatrics, and the Department of Pathology and Laboratory Medicine,{dagger}
University of Florida Brain Institute and College of Medicine, Gainesville, Florida

Dermal and plexiform neurofibromas are peripheral nerve sheath tumors that arise frequently in neurofibromatosis type 1. The goal of the present study was to examine the tumorigenic properties of neurofibromin-deficient human Schwann cells (SCs) that were found to represent a subset of SCs present in approximately half of the total neurofibromas examined. Highly enriched SC cultures were established from 10 dermal and eight plexiform neurofibromas by selective subculture using glial growth factor-2 and laminin. These cultures had low tumorigenic potential in classical in vitro assays yet several unique preneoplastic properties were frequently observed, including delayed senescence, a lack of density-limited growth, and a strong propensity to spontaneously form proliferative cell aggregates rich in extracellular matrix. Western blot analysis failed to detect full-length neurofibromin in any of the neurofibroma SC cultures, indicating that neurofibromin-deficient SCs had a substantial growth advantage. Immunohistochemical staining of the originating tumors showed the majority were comprised principally of neurofibromin-negative SCs, whereas the remainder contained both neurofibromin-negative and neurofibromin-positive SCs. Lastly, engraftment of neurofibromin-deficient SC cultures into the peripheral nerves of scid mice consistently produced persistent neurofibroma-like tumors with diffuse and often extensive intraneural growth. These findings indicate that neurofibromin-deficient SCs are involved in neurofibroma formation and, by selective subculture, provide a resource for the development of an in vivo model to further examine the role of these mutant SCs in neurofibroma histogenesis.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
S. Liu, Y. Tian, A. Chlenski, Q. Yang, P. Zage, H. R. Salwen, S. E. Crawford, and S. L. Cohn
Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts
Am. J. Pathol., March 1, 2005; 166(3): 891 - 900.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Plexiform neurofibromas in NF1: Toward biologic-based therapy
Neurology, May 28, 2002; 58(10): 1461 - 1470.



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.